Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-23-000118
Filing Date
2023-03-24
Accepted
2023-03-24 19:03:21
Documents
1
Period of Report
2023-03-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 24680
  Complete submission text file 0000874015-23-000118.txt   26125
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
Birchler Brian (Reporting) CIK: 0001970151 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 23761141